BATF3 and neoplasm: Support for this hypothesis has been demonstrated in-vivo, where versikine-overexpressing murine lung, breast and myeloma tumours displayed a significant increase in Batf3-expressing dendritic cells when compared to tumours from empty-vector control cells [141].